Skip to main content

Table 1 Patient demographics of those undergoing liver transplantation for polycystic liver disease

From: Liver transplantation in adult polycystic liver disease: the Ontario experience

Variable Total Male Female
Number of Transplants 51 (100%) 8 (16%) 43 (84%)
Median age* 54 (46–59) 62 (59–64) 52 (45–56)
Median Waitlist (months) 9.8 (5.5–18.7) 10.2 (7.4–14.1) 9.5 (5–18.8)
Median MELD score at time of transplant 13 (7–22) 22 (17–22) 10 (6–21)
Median (years) follow up 6.3 (12.5) 2.9 (2.2–4.1) 8 (3–13.8)
Orthotopic Liver transplant 46 (90.1%) 8 (15.6%) 38 (74.5%)
Living donor 5 (9.8%) 0 (0%) 5 (9.8%)
Liver transplant alone 29 (56.8%) 1 (1.9%) 28 (54.9%)
Kidney first then liver transplant 15 (29.4%) 3 (5.8%) 12 (23.5%)
Simultaneous Liver-Kidney transplant (SLK) 7 (13.7%) 4 (7.8%) 3 (5.8%)
Median Creatinine \((\upmu\) mol) 101 (80–319) 426 (237–485) 91 (73–184)
Median Hemoglobin (g/L) 116(109–126) 118 (113–127) 116 (109–127)
Median platelet (109/L)* 189 (130–239) 189 (118– 203) 193 (132–240)
Median Bilirubin \(\upmu\) mol* 10 (8–14) 10 (9–11) 10 (7–14)
Median INR* 1.1 (1–1.2) 1.2 (1.15–1.2) 1.1 (1–1.2)
Median Albumin (g/L)* 40 (35–43) 36 (33–40) 40 (35–43)
Death 4 (7.8%) 1 (1.9%) 3 (5.8%)
  1. *Medians expressed as IQR